Question 1

How does Rohitaka work for liver disorders?

Accepted Answer

Rohitaka (Tecomella undulata) contains bioactive compounds including tecomin, lapachol, and ursolic acid that demonstrate hepatoprotective properties. These compounds work through antioxidant mechanisms that help neutralize free radicals and reduce oxidative stress in liver cells. The bark also contains beta-sitosterol and oleanolic acid, which may support liver cell membrane stability and promote regeneration of damaged hepatic tissue. Evidence level C suggests preliminary research supports these mechanisms, though more rigorous clinical studies are needed to fully establish the hepatoprotective pathway.

Question 2

Does Rohitaka interact with any medications?

Accepted Answer

Rohitaka may potentially interact with hepatotoxic medications and drugs metabolized by the liver. Due to its effects on liver function, concurrent use with acetaminophen, statins, or other liver-affecting medications requires medical supervision. The herb may also alter the metabolism of drugs processed through cytochrome P450 enzymes. Patients taking immunosuppressants or anticoagulants should exercise caution. Evidence level C indicates limited interaction data exists, so consulting a healthcare provider before combining Rohitaka with prescription medications is strongly recommended.

Question 3

What is the recommended dosage of Rohitaka bark?

Accepted Answer

The traditional Ayurvedic dosage for Rohitaka bark powder is 3-5 grams daily, typically divided into two doses. For standardized extracts, 500mg taken twice daily is commonly recommended. The bark can be consumed as a decoction, powder mixed with warm water, or in tablet form. Dosage should be adjusted based on individual constitution, condition severity, and practitioner guidance. Starting with lower doses and gradually increasing helps assess tolerance. Evidence level C supports these traditional dosing recommendations.

Question 4

Is Rohitaka safe during pregnancy and breastfeeding?

Accepted Answer

Rohitaka is contraindicated during pregnancy and lactation and should be strictly avoided. The herb contains compounds that may stimulate uterine contractions and potentially cause miscarriage or harm to the developing fetus. During breastfeeding, active constituents may pass into breast milk and affect the infant. Women who are pregnant, planning pregnancy, or nursing should not use Rohitaka in any form. Evidence level C indicates these safety concerns are based on traditional knowledge and preliminary research, warranting absolute caution.

Question 5

What are the side effects of Rohitaka?

Accepted Answer

Rohitaka is generally well-tolerated at recommended doses, but some individuals may experience mild side effects. The most common include mild laxative effects and digestive upset, particularly at higher doses. Some users report mild gastrointestinal discomfort, nausea, or loose stools. These effects typically resolve with dose reduction or discontinuation. Severe adverse reactions are rare when used appropriately. Those with acute liver failure should avoid Rohitaka entirely. Evidence level C indicates safety data is primarily from traditional use rather than extensive clinical trials.

Question 6

What is Rohitaka used for in Ayurveda?

Accepted Answer

Rohitaka (Tecomella undulata) is primarily used in Ayurveda for treating liver and spleen disorders, including hepatomegaly (liver enlargement) and splenomegaly (spleen enlargement). It is valued for its hepatoprotective properties and is traditionally prescribed for anemia, skin diseases, and various liver conditions. The bark is considered the most medicinally potent part of the plant. Its bitter and astringent properties help balance pitta and kapha doshas. Evidence level C supports these traditional applications, though more clinical research is needed to validate efficacy.

Rohitaka

Sources et citations

Dicranostigma leptopodum

Bauhinia tomentosa

Tephrosia purpurea

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Synthèse des preuves

Sources PubMed

Sources gouvernementales